Cargando…
Arterial Transit Time Mapping Obtained by Pulsed Continuous 3D ASL Imaging with Multiple Post-Label Delay Acquisitions: Comparative Study with PET-CBF in Patients with Chronic Occlusive Cerebrovascular Disease
Arterial transit time (ATT) is most crucial for measuring absolute cerebral blood flow (CBF) by arterial spin labeling (ASL), a noninvasive magnetic resonance (MR) perfusion assessment technique, in patients with chronic occlusive cerebrovascular disease. We validated ASL-CBF and ASL-ATT maps calcul...
Autores principales: | Tsujikawa, Tetsuya, Kimura, Hirohiko, Matsuda, Tsuyoshi, Fujiwara, Yasuhiro, Isozaki, Makoto, Kikuta, Ken-ichiro, Okazawa, Hidehiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4898726/ https://www.ncbi.nlm.nih.gov/pubmed/27275779 http://dx.doi.org/10.1371/journal.pone.0156005 |
Ejemplares similares
-
Assessment of Arterial Transit Time and Cerebrovascular Reactivity in Moyamoya Disease by Simultaneous PET/MRI
por: Takata, Kenji, et al.
Publicado: (2023) -
No significant difference found in PET/MRI CBF values reconstructed with CT-atlas-based and ZTE MR attenuation correction
por: Okazawa, Hidehiko, et al.
Publicado: (2019) -
Differences in Hemodynamic Alteration between Atherosclerotic Occlusive Lesions and Moyamoya Disease: A Quantitative (15)O-PET Study
por: Igarashi, Chiaki, et al.
Publicado: (2021) -
Correction: Arterial Transit Time Mapping Obtained by Pulsed Continuous 3D ASL Imaging with Multiple Post-Label Delay Acquisitions: Comparative Study with PET-CBF in Patients with Chronic Occlusive Cerebrovascular Disease
Publicado: (2016) -
The Utility of Arterial Transit Time Measurement for Evaluating the Hemodynamic Perfusion State of Patients with Chronic Cerebrovascular Stenosis or Occlusive Disease: Correlative Study between MR Imaging and (15)O-labeled H(2)O Positron Emission Tomography
por: Takeuchi, Kayo, et al.
Publicado: (2022)